Navigation Links
Omega-3 Supplements Show Promise in Alleviating Depression
Date:12/7/2010

MIAMI, Dec. 8, 2010 /PRNewswire-USNewswire/ -- A new analysis of the effects of omega-3 essential fatty acids offers the hope of enhanced treatment options for tens of millions of people with depression. Two critical omega-3 essential fatty acids available from certain food or nutritional supplements but not manufactured by the body—Eicosapentenoic acid (EPA) and docosahexaenoic (DHA) — play a role in optimal brain functioning and have antidepressant benefits that have not been fully recognized.  The results were presented today at the annual meeting of the American College of Neuropsychopharmacology.

In a meta-analysis of 15 randomized, double-blind, placebo-controlled studies, researchers from the University of Illinois at Chicago, led by John M. Davis, M.D., research professor at the University of Illinois at Chicago and ACNP member, found that patients taking omega-3 with either EPA or a combination of EPA and DHA experienced clear antidepressant benefits. However, across studies, patients taking the pure DHA form of omega-3 saw no antidepressant effect.

"Our analysis clarifies the precise type of omega-3 fatty acid that is effective for people with depression and explains why previous findings have been contradictory," said Davis. "The EPA predominant formulation is necessary for the therapeutic action to occur. The DHA predominant formulation does not have antidepressant efficacy."

While scientists noted that omega-3 produces beneficial effects in patients with depression, EPA does not improve mood in people who are not depressed. In several studies, people without depression experienced no difference in mood as a result of omega-3 consumption. In another study Davis and his team found that women with inadequate omega-3 intake were more likely to experience depression during and after pregnancy than women with adequate omega-3 in their diets.

"The findings are unambiguous," said Davis. "Omega-3 fatty acids have antidepressant properties, and this effect is ready to be tested in a large study to establish the dose range and to pave the way for FDA approval. In the meantime, omega-3 fatty acids containing EPA could be useful to augment effects of antidepressant medications.  However, scientists caution that patients should always talk with their mental health professional before taking omega-3 fatty acids to alleviate symptoms of depression."

Approximately 20.9 million American adults suffer from mood disorders, including depression, the world's fourth leading cause of morbidity and death.


'/>"/>
SOURCE American College of Neuropsychopharmacology
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. New Data Shows Prescription Omega-3 Acid Ethyl Esters Reduced the Incidence of Death in Heart Failure Patients
2. Study Shows Benefits of a High Omega-3 Diet in Older Adults
3. Scientists Reveal Roadmap to Brain Health That Can Be Passed Down to Future Generations: Exercise, Omega-3, Folic Acid, Vitamin B6, and Vitamin B12
4. Omega-3 Fatty Acids Critical to Infants, Mothers and the Seriously Ill
5. Pregnant Women Need Omega-3 to Boost Infant Development
6. Mayo Clinic Proceedings Contributors Highlight Research Findings About Cardiovascular Benefits Associated With Omega-3 Fatty Acids
7. Seeking Safety in Supplements
8. SCOLR Pharma, Inc. Licenses Dietary Supplements
9. Longevity Seekers Advised to Consume Modest Doses of Red Wine Molecules in Dietary Supplements (Longevinex(R)) Rather than Mega-Dose Resveratrol Alone
10. Nationwide Survey Shows Infertility Patients Prefer ENDOMETRIN(R) Compared With Other Progesterone Supplements
11. Resveratrol Longevity Science Makes Dramatic U-Turn, But Resveratrol Supplements Remain Unchanged
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/7/2016)... , Dec. 7, 2016 According to responses ... more than one-third (38%) of patients with non-small cell lung ... growth factor receptor (EGFR) genetic mutation status. The findings of ... LBA ID #6067 #P3.02b ) at the 2016 ... Austria . The survey results revealed an ...
(Date:12/7/2016)... Boehringer Ingelheim today announced that the ... malignant pleural mesothelioma (MPM) met its primary endpoint ... the 17 th IASLC World Conference on ... showed nintedanib plus pemetrexed/cisplatin demonstrated a meaningful clinical ... significantly improved PFS (9.4 vs 5.7 months). Preliminary ...
(Date:12/7/2016)... 7, 2016 Today, Stock-Callers.com presents four ... JAZZ ), Anthera Pharmaceuticals Inc. (NASDAQ: ANTH ... AveXis Inc. (NASDAQ: AVXS ). From its peak ... 37% to reach a level equal to what it saw ... approximately 14% for the year, it has still out-performed other ...
Breaking Medicine Technology:
(Date:12/7/2016)... ... December 07, 2016 , ... Texas Premier Locksmith ... carried out by unethical locksmith companies and is urging Search Engines to improve ... to Texas Premier Locksmith, these fraudulent locksmith services take advantage of consumers locked ...
(Date:12/7/2016)... ... December 07, 2016 , ... Gensuite is honored ... under the Best New Product Launch category. Gensuite’s entry on their EZ Scan ... BOC Global Events & Training Group is a professional event and training provider ...
(Date:12/7/2016)... ... December 07, 2016 , ... “Tomorrow Trump Goes To ... bringing greatness back to the presidency and to America. “Tomorrow Trump Goes To Washington” ... as much as she can for this country. , Nancy attributes her patriotic nature ...
(Date:12/7/2016)... ... 2016 , ... The Business Architecture Guild is ... on March 21-22, 2017. This premier event features business practitioners and experts from ... of industries such as financial services, insurance, healthcare, manufacturing, transportation, retail, and utilities. ...
(Date:12/6/2016)... ... December 06, 2016 , ... ... that can be seen on a type of MRI, according to a study ... disorder of the central nervous system characterized by tremors or trembling and stiffness ...
Breaking Medicine News(10 mins):